Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with chronic, high-risk, NYHA class II or III heart failure with reduced ejection fraction (HFrEF), especially among those who have higher levels of inflammation, yet hospitalization was not reduced, according to late-breaking research presented today at the American Heart […]
Home »
Modest differences in lung function could offer clues about the risk of sudden cardiac death
People who have modestly but measurably worse lung function are more likely to suffer sudden cardiac death (SCD), according to research presented at the European Respiratory Society International Congress. SCD is an unexpected death that results from a sudden malfunction in the heart and in many people who suffer SCD, there are no previous warning […]
Heart problems resolve in majority of kids with COVID inflammatory syndrome
Heart problems in children hospitalized with multisystem inflammatory syndrome (MIS-C)—an inflammatory condition triggered by COVID—were mostly gone within a few months, a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found. The study published in Pediatrics about 45 MIS-C patients is the first in North America to […]
Heart problems in kids with MIS-C resolve rapidly, study shows
Heart problems in children hospitalized with multisystem inflammatory syndrome (MIS-C)–an inflammatory condition triggered by COVID–were mostly gone within a few months, a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian has found. The study published in Pediatrics about 45 MIS-C patients is the first in North America to […]
Study provides the most comprehensive look yet on COVID-19 hospital mortality
A new study of hospital deaths in the United States, published today in JAMA Network Open, is the most comprehensive look yet at changes in hospital mortality during the pandemic. Researchers analyzed data on more than 20,000 patients admitted to hospitals for COVID-19, over nine full months, from March to November of 2020. They found […]
COVID-19 deadlier than cars for over 40s, study finds
The death toll from the coronavirus disease (COVID-19) pandemic has been unparalleled due to both the high number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the seriousness of the disease. Researchers from the artificial intelligence software company nference report that the deaths due to COVID-19 over the last 12 months are higher […]
Mouse model closely replicates human NAFLD
Human non-alcoholic fatty liver disease (NAFLD) is a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver cancer and ultimately requires liver transplant. "NAFLD has been difficult to study mainly because we had no good animal model," said corresponding author Dr. Karl-Dimiter Bissig, who was at Baylor during the development of this […]
Dapagliflozin Effective in Both Women and Men With Heart Failure With Reduced Ejection Fraction
NEW YORK (Reuters Health) – Unlike some heart failure (HF) treatments that affect women and men differently, dapagliflozin reduces the risk of worsening HF and death and improved symptoms, function, and quality of life similarly in both sexes, researchers say. “Given that SGLT2 inhibitors are a major breakthrough for the treatment of heart failure, it […]
Contraceptive planning is essential to optimal health for women with heart disease
Pregnancy can increase the risk of morbidity and mortality in women with cardiovascular disease; however, many cardiologists are not having pre-pregnancy contraception discussions with their patients of child-bearing age. There is a need to provide evidence-based guidance for contraceptive safety and effectiveness and pregnancy planning options for this high-risk patient group, according to a paper […]
Screen time for older adults: Mobile health tech can support seniors with heart disease
Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart disease, yet more research is needed to determine what methods are the most effective, according to a new scientific statement from the American Heart Association published today in the American Heart Association […]